BONE BIOLOGICS CORP (BBLG)
US0980705018 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||||||||||
| EBITDA YoY % growth | N/A | -2.13M | -12M -463.38% | -20.41M -70.08% | -2.63M 87.11% | -2.79M -6.08% | -2.45M 12.19% | -830K 66.12% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -670K | -2.13M -217.91% | -12M -463.38% | -20.41M -70.08% | -2.63M 87.11% | -2.79M -6.08% | -2.45M 12.19% | -830K 66.12% | -1.1M -32.53% | -3.67M -233.64% | -9.428M -156.90% | N/A -89,948.38% | N/A 99.95% | N/A -5.91% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -50.40 68.81% | -66.39 -31.73% | N/A 92.32% | N/A 61.00% | N/A -1.03% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.66 73.16% | -0.49 62.63% | -0.46 31.49% | -0.50 78.91% | -0.54 18.46% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.22M -5.16% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -2.37 51.43% | -0.61 | -1.76 | -287.25% |
| Q2 2024 Q2Q % growth | -0.67 82.55% | -1.42 | 0.75 | 52.74% |
| Q1 2024 Q2Q % growth | -1.31 97.63% | -7.75 | 6.44 | 83.10% |
| Q4 2023 Q2Q % growth | -2.47 94.28% | -5.71 | 3.24 | 56.76% |
| Q3 2023 Q2Q % growth | -4.88 -35.56% | -24.81 | 19.93 | 80.33% |
| Q2 2023 Q2Q % growth | -3.84 -156.00% | -12.24 | 8.40 | 68.63% |
| Q1 2023 Q2Q % growth | -55.20 -2,528.57% | -17.14 | -38.06 | -222.13% |
| Q4 2022 Q2Q % growth | -43.20 -730.45% | -55.08 | 11.88 | 21.57% |
| Q3 2022 Q2Q % growth | -3.60 -2,017.65% | -4.59 | 0.99 | 21.57% |
| Q2 2022 Q2Q % growth | -1.50 | -3.67 | 2.17 | 59.15% |
| Q1 2022 Q2Q % growth | -2.10 | -6.12 | 4.02 | 65.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 91.5% | 91.5% | -57.73% | -57.73% |
| Revenue | N/A | N/A | N/A | N/A |